148 related articles for article (PubMed ID: 1689578)
1. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
McHugh MM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1990 Feb; 39(4):707-14. PubMed ID: 1689578
[TBL] [Abstract][Full Text] [Related]
2. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
Woynarowski JM; Sigmund RD; Beerman TA
Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776
[TBL] [Abstract][Full Text] [Related]
3. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
[TBL] [Abstract][Full Text] [Related]
4. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
[TBL] [Abstract][Full Text] [Related]
5. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
Yamamoto K; Kawanishi S
Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
[TBL] [Abstract][Full Text] [Related]
6. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Fesen M; Pommier Y
J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
[TBL] [Abstract][Full Text] [Related]
7. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
Smith PJ; Bell SM; Dee A; Sykes H
Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
Poot M; Hiller KH; Heimpel S; Hoehn H
Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
[TBL] [Abstract][Full Text] [Related]
9. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors.
Chen AY; Yu C; Gatto B; Liu LF
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8131-5. PubMed ID: 7690143
[TBL] [Abstract][Full Text] [Related]
10. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA.
Chiang SY; Welch J; Rauscher FJ; Beerman TA
Biochemistry; 1994 Jun; 33(23):7033-40. PubMed ID: 7516181
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a protein recognizing minor groove binders-damaged DNA.
Colella G; Bonfanti M; D'Incalci M; Broggini M
Nucleic Acids Res; 1996 Nov; 24(21):4227-33. PubMed ID: 8932377
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells.
Mattern MR; Mong SM; Bartus HF; Mirabelli CK; Crooke ST; Johnson RK
Cancer Res; 1987 Apr; 47(7):1793-8. PubMed ID: 3028614
[TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang YH; Liu LF; Wall ME; Wani MC; Nicholas AW; Manikumar G; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Aug; 49(16):4385-9. PubMed ID: 2545341
[TBL] [Abstract][Full Text] [Related]
14. Structural modifications induced in Chinese hamster V79--E chromosomes by prefixation treatment in vitro with the AT-specific agents netropsin, distamycin A, and Hoechst 33258.
Thust R; Rønne M
Hereditas; 1981; 94(2):209-13. PubMed ID: 6170606
[No Abstract] [Full Text] [Related]
15. Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
Ginsburg H; Nissani E; Krugliak M; Williamson DH
Mol Biochem Parasitol; 1993 Mar; 58(1):7-15. PubMed ID: 7681547
[TBL] [Abstract][Full Text] [Related]
16. Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities.
Beerman TA; McHugh MM; Sigmund R; Lown JW; Rao KE; Bathini Y
Biochim Biophys Acta; 1992 May; 1131(1):53-61. PubMed ID: 1374646
[TBL] [Abstract][Full Text] [Related]
17. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
Yamamoto K; Sugiyama H; Kawanishi S
Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
19. Molecular recognition of B-DNA by Hoechst 33258.
Harshman KD; Dervan PB
Nucleic Acids Res; 1985 Jul; 13(13):4825-35. PubMed ID: 2410856
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
